RAPA-501-Allo Therapy of COVID-19-ARDS
NCT04482699
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class
Stopped
Change in eligible patient population
Conditions
Severe COVID-19 Disease
Interventions
BIOLOGICAL:
RAPA-501-Allo off-the-shelf Therapy of COVID-19
OTHER:
Placebo
Sponsor
Rapa Therapeutics LLC
Collaborators
[object Object]